← Back to Patent Explorer
US3954733A Expired / Lapsed US ⏱️ 0.0 years remaining

Naphthyridine-3-carboxamido-benzylpenicillins and salts thereof

Assignee: Sumitomo Chemical Co Ltd
•
Filing: 1973-12-13
•
Granted: 1976-05-04
•
Expires: 1993-12-13
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Novel penicillins of the formula:

Inventors

  • 👤 Hisao Tobiki
  • 👤 Hirotada Yamada
  • 👤 Iwao Nakatsuka
  • 👤 Kozo Shimago
  • 👤 Shigeru Okano
  • 👤 Takenari Nakagome
  • 👤 Toshiaki Komatsu
  • 👤 Akio Izawa
  • 👤 Hiroshi Noguchi
  • 👤 Yasuko Eda

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-25 17:40
CPC Classifications
C; C07; C07D; C07D471/00; C07D471/02; C07D471/04; C07D499/00

Claims Analysis

Total Claims: 32
Claim 1
Independent Claim 93 words
A compound of the formula: ##SPC24## wherein the ring A is an unsubstituted pyridine ring or a pyridine ring having one or more substituents selected from the group consisting of lower alkyl, lower alkoxy, lower alkylthio, lower haloalkyl, lower alkylenedioxy, halogen, hydroxyl, nitro, amino, lower alkoxycarbonylamino, lower alkylamino, di(lower) alkylamino and lower alkanoylamino, X is oxygen or sulfur, Y is hydrogen, lower alkoxycarbonyl or lower alkanoyl, R 1 is hydroxyl, lower alkanoyloxy, lower alkoxycarbonyloxy or benzyloxycarbonyloxy and R 2 and R 3 are each hydrogen or halogen, and nontoxic pharmaceutically acceptable salts thereof.
Claim 2
Dependent Claim 93 words
A compound of the formula: ##SPC24## wherein the ring A is an unsubstituted pyridine ring or a pyridine ring having one or more substituents selected from the group consisting of lower alkyl, lower alkoxy, lower alkylthio, lower haloalkyl, lower alkylenedioxy, halogen, hydroxyl, nitro, amino, lower alkoxycarbonylamino, lower alkylamino, di(lower) alkylamino and lower alkanoylamino, X is oxygen or sulfur, Y is hydrogen, lower alkoxycarbonyl or lower alkanoyl, R 1 is hydroxyl, lower alkanoyloxy, lower alkoxycarbonyloxy or benzyloxycarbonyloxy and R 2 and R 3 are each hydrogen or halogen, and nontoxic pharmaceutically acceptable salts thereof.
Claim 3
Dependent Claim 33 words
The compound according to claim 1, wherein the ring A is an unsubstituted pyridine ring or a pyridine ring substituted with one or more of dimethylamino, methyl, methylthio, methoxy, hydroxyl, acetylamino and amino.
Claim 4
Dependent Claim 32 words
The compound according to claim 2, wherein R 1 is a hydroxyl group or an ethoxycarbonyloxy group and R 2 and R 3 are each a hydrogen atom or a chlorine atom.
Claim 5
Dependent Claim 79 words
A compound of the formula: ##SPC25## wherein the ring A is an unsubstituted pyridine ring or a pyridine ring having one or more substituents selected from the group consisting of lower alkyl, lower alkoxy, lower alkylthio, lower haloalkyl, lower alkylenedioxy, halogen, hydroxyl, nitro, amino, lower alkoxycarbonylamino, lower alkylamino, di(lower)alkylamino and lower alkanoylamino, R 1 is hydroxyl, lower alkanoyloxy, lower alkoxycarbonyloxy or benzyloxycarbonyloxy and R 2 and R 3 are each hydrogen or halogen, and nontoxic pharmaceutically acceptable salts thereof.
Claim 6
Dependent Claim 79 words
A compound of the formula: ##SPC25## wherein the ring A is an unsubstituted pyridine ring or a pyridine ring having one or more substituents selected from the group consisting of lower alkyl, lower alkoxy, lower alkylthio, lower haloalkyl, lower alkylenedioxy, halogen, hydroxyl, nitro, amino, lower alkoxycarbonylamino, lower alkylamino, di(lower)alkylamino and lower alkanoylamino, R 1 is hydroxyl, lower alkanoyloxy, lower alkoxycarbonyloxy or benzyloxycarbonyloxy and R 2 and R 3 are each hydrogen or halogen, and nontoxic pharmaceutically acceptable salts thereof.
Claim 7
Dependent Claim 80 words
A compound of the formula: ##SPC26## wherein the ring A is an unsubstituted pyridine ring or a pyridine ring having one or more substituents selected from the group consisting of lower alkyl, lower alkoxy, lower alkylthio, lower alkanoylamino, hydroxyl, di(lower)alkylamino and amino, X is oxygen or sulfur, Y is hydrogen, lower alkoxycarbonyl or lower alkanoyl, R 1 is hydroxyl, lower alkoxycarbonyloxy or benzyloxycarbonyloxy and R 2 and R 3 are each hydrogen or halogen, and non-toxic pharmaceutically acceptable salts thereof.
Claim 8
Dependent Claim 80 words
A compound of the formula: ##SPC26## wherein the ring A is an unsubstituted pyridine ring or a pyridine ring having one or more substituents selected from the group consisting of lower alkyl, lower alkoxy, lower alkylthio, lower alkanoylamino, hydroxyl, di(lower)alkylamino and amino, X is oxygen or sulfur, Y is hydrogen, lower alkoxycarbonyl or lower alkanoyl, R 1 is hydroxyl, lower alkoxycarbonyloxy or benzyloxycarbonyloxy and R 2 and R 3 are each hydrogen or halogen, and non-toxic pharmaceutically acceptable salts thereof.
Claim 9
Dependent Claim 12 words
The compound according to claim 1, wherein Y is a hydrogen atom.
Claim 10
Dependent Claim 39 words
The compound according to claim 1, wherein R 1 is a hydroxyl group, a C 1 -C 6 alkoxycarbonyloxy group or a benzyloxycarbonyloxy group and R 2 and R 3 are each a hydrogen atom or a chlorine atom.
Claim 11
Dependent Claim 7 words
D-α-(4-Hydroxy-1,5-naphthyridine-3-carboxamido)-p-hydroxybenzylpenicillin and non-toxic, pharmaceutically acceptable salts thereof.
Claim 12
Dependent Claim 7 words
D-α-(4-Hydroxy-1,5-naphthyridine-3-carboxamido)-p-hydroxybenzylpenicillin and non-toxic, pharmaceutically acceptable salts thereof.
Claim 13
Dependent Claim 7 words
D-α-(4-Ethoxycarbonyloxy-1,5-naphthyridine-3-carboxamido)-p-benzyloxycarbonyloxybenzylpenicillin and nontoxic, pharmaceutically acceptable salts thereof.
Claim 14
Dependent Claim 7 words
D-α-(4-Ethoxycarbonyloxy-1,5-naphthyridine-3-carboxamido)-p-benzyloxycarbonyloxybenzylpenicillin and nontoxic, pharmaceutically acceptable salts thereof.
Claim 15
Dependent Claim 7 words
D-α-(4-Hydroxy-7-methyl-1,8-naphthyridine-3-carboxamido)-p-hydroxybenzylpenicillin and non-toxic, pharmaceutically acceptable salts thereof.
Claim 16
Dependent Claim 7 words
D-α-(4-Hydroxy-7-methyl-1,8-naphthyridine-3-carboxamido)-p-hydroxybenzylpenicillin and non-toxic, pharmaceutically acceptable salts thereof.
Claim 17
Dependent Claim 7 words
D-α-(4-Hydroxy-1,5-naphthyridine-3-carboxamido)-p-ethoxycarbonyloxybenzylpenicillin and non-toxic, pharmaceutically acceptable salts thereof.
Claim 18
Dependent Claim 7 words
D-α-(4-Hydroxy-1,5-naphthyridine-3-carboxamido)-p-ethoxycarbonyloxybenzylpenicillin and non-toxic, pharmaceutically acceptable salts thereof.
Claim 19
Dependent Claim 7 words
D-α-(4-Hydroxy-1,5-naphthyridine-3-carboxamido)-m-hydroxybenzylpenicillin and non-toxic, pharmaceutically acceptable salts thereof.
Claim 20
Dependent Claim 7 words
D-α-(4-Hydroxy-1,5-naphthyridine-3-carboxamido)-m-hydroxybenzylpenicillin and non-toxic, pharmaceutically acceptable salts thereof.
Claim 21
Dependent Claim 7 words
D-α-(4-Hydroxy-6-methyl-1,5-naphthyridine-3carboxamido)-p-hydroxybenzylpenicillin and non-toxic, pharmaceutically acceptable salts thereof.
Claim 22
Dependent Claim 7 words
D-α-(4-Hydroxy-6-methyl-1,5-naphthyridine-3carboxamido)-p-hydroxybenzylpenicillin and non-toxic, pharmaceutically acceptable salts thereof.
Claim 23
Dependent Claim 7 words
D-α-(4,6-Dihydroxy-1,5-naphthyridine-3-carboxamido)-p-hydroxybenzylpenicillin and non-toxic, pharmaceutically acceptable salts thereof.
Claim 24
Dependent Claim 7 words
D-α-(4,6-Dihydroxy-1,5-naphthyridine-3-carboxamido)-p-hydroxybenzylpenicillin and non-toxic, pharmaceutically acceptable salts thereof.
Claim 25
Dependent Claim 7 words
D-α-(6-Amino-4-hydroxy-1,5-naphthyridine-3-carboxamido)-p-hydroxybenzylpenicillin and non-toxic, pharmaceutically acceptable salts thereof.
Claim 26
Dependent Claim 7 words
D-α-(6-Amino-4-hydroxy-1,5-naphthyridine-3-carboxamido)-p-hydroxybenzylpenicillin and non-toxic, pharmaceutically acceptable salts thereof.
Claim 27
Dependent Claim 7 words
D-α-(4-Hydroxy-1,5-naphthyridine-3-carboxamido)-m-chloro-p-hydroxybenzylpenicillin and non-toxic, pharmaceutically acceptable salt thereof.
Claim 28
Dependent Claim 7 words
D-α-(4-Hydroxy-1,5-naphthyridine-3-carboxamido)-m-chloro-p-hydroxybenzylpenicillin and non-toxic, pharmaceutically acceptable salt thereof.
Claim 29
Dependent Claim 7 words
D-α-(4-Ethoxycarbonyloxy-1,5-naphthyridine-3-carboxamido)-p-ethoxycarbonyloxybenzylpenicillin and nontoxic, pharmaceutically acceptable salts thereof.
Claim 30
Dependent Claim 7 words
D-α-(4-Ethoxycarbonyloxy-1,5-naphthyridine-3-carboxamido)-p-ethoxycarbonyloxybenzylpenicillin and nontoxic, pharmaceutically acceptable salts thereof.
Claim 31
Dependent Claim 7 words
D-α-(4-Mercapto-1,5-naphthyridine-3-carboxamido)-p-hydroxybenzylpenicillin and non-toxic, pharmaceutically acceptable salts thereof.
Claim 32
Dependent Claim 7 words
D-α-(4-Mercapto-1,5-naphthyridine-3-carboxamido)-p-hydroxybenzylpenicillin and non-toxic, pharmaceutically acceptable salts thereof.

References Cited (Backward Citations)

US3248387A Cited
US3453264A Cited
US3433784A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1979-05-04 1979-11-03 1980-05-04 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1983-05-04 1983-11-03 1984-05-04 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1987-05-04 1987-11-03 1988-05-04 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag